| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC09 |
| UNII: | M2HPV837HO |
Pharmacology
| Primary Target | |
|---|---|
| CD3e |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
| Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Ascites | 2 | D001201 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 509077-98-9 |
| ChEMBL | CHEMBL2108581 |
| FDA SRS | M2HPV837HO |
| Guide to Pharmacology | 7385 |
CONTENTS